Sal Ceja
Principal, Architect, AIA, LEED AP, EwingCole
Sal is a Principal and Facility Planner in the Science + Technology practice at EwingCole, Sal is focused on the design of state of the art cGMP facilities. He has specialized in the design and planning of complicated buildings for the Life Sciences and Bio-pharmaceutical industry. Sal’s experience includes science and technology, biomedical research, medical device manufacturing, healthcare and pharmaceutical facilities. Some of the most recent facilities he specializes in include clinical and commercial manufacturing facilities for Cell & Gene Therapies, Quality Control Laboratories, and Research/Process & Development laboratories. His expertise includes providing comprehensive design and project management services, from client consultation and conceptual design through construction contract administration services.
Appearances
DateJanuary 29, 2024This presentation will cover the exciting new project designed for the Roche Cell & Gene Therapy network…Speakers
Principal, Architect, AIA, LEED AP, EwingColeSr. Principal Architect, Genentech
DateOctober 16, 2023Building for Success! The journey of introducing a new therapy to the market involves more than just its development. Join our upcoming session to explore the critical role of facility design and construction in the success of a therapy…Session Leader
QA Specialist, Bachem AGSpeakers
Principal, Architect, AIA, LEED AP, EwingColeCell & Gene Therapy Advanced Manufacturing Lead, Vertex PharmaceuticalsSite Head & Vice President Manufacturing, WuXi Biologics (Shanghai) Co., Ltd.Senior Director, Head of Engineering, WuXi BiologicsVice President and General Manager, Turner Construction CoChief Operating Officer, SPIN Biotech Consulting LLCEmily Heffernan, PEUS Director, New Process Technology, Arcadis DPS GroupCEO, SPIN Biotech Consultant, LLC
